An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

S Drożdżal, J Rosik, K Lechowicz, F Machaj… - Drug Resistance …, 2021 - Elsevier
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …

[HTML][HTML] Cardiovascular complications of COVID-19

F Farshidfar, N Koleini, H Ardehali - JCI insight, 2021 - ncbi.nlm.nih.gov
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …

[HTML][HTML] Fast-track development of vaccines for SARS-CoV-2: the shots that saved the world

VP Chavda, Q Yao, LK Vora, V Apostolopoulos… - Frontiers in …, 2022 - frontiersin.org
In December 2019, an outbreak emerged of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) which leads to coronavirus disease 2019 (COVID-19). The World Health …

[HTML][HTML] Hematological abnormalities in COVID-19: a narrative review

A Rahman, R Niloofa, U Jayarajah… - The American journal …, 2021 - ncbi.nlm.nih.gov
ABSTRACT COVID-19 is caused by SARS-CoV-2. Although pulmonary manifestations have
been identified as the major symptoms, several hematological abnormalities have also been …

[HTML][HTML] Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena

VP Chavda, MK Hossain, J Beladiya, V Apostolopoulos - Biologics, 2021 - mdpi.com
Coronavirus disease, COVID-19, has touched every country globally except five countries
(North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective …

[HTML][HTML] Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19

F Vahedifard, K Chakravarthy - Emergent materials, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the recent
outbreak of coronavirus 2019 (COVID-19). Although nearly two decades have passed since …

A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment

RP Nippes, PD Macruz, GN da Silva… - Process Safety and …, 2021 - Elsevier
Abstract On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a
pandemic. The outbreak caused a worldwide impact, becoming a health threat to the …

[HTML][HTML] An update on antiviral therapy against SARS-CoV-2: how far have we come?

O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …

[HTML][HTML] Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database

V Gupte, R Hegde, S Sawant, K Kalathingal… - BMC infectious …, 2022 - Springer
Background Real-world data on safety and clinical outcomes of remdesivir in COVID-19
management is scant. We present findings of data analysis conducted for assessing the …

[HTML][HTML] Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

MS Mirtaleb, AH Mirtaleb, H Nosrati… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China,
in December 2020 and coronavirus disease 19 (COVID-19) was later announced as …